Latest Investor Relations News

Memphasys Limited has successfully raised over $1.1 million through a pro-rata entitlement offer to accelerate the commercialisation of its innovative Felix™ sperm selection system, targeting key regulatory approvals and market expansion.

Monadelphous Group Limited has raised its revenue guidance for 2025, buoyed by strong contract awards and elevated activity across its engineering and construction divisions.

Alliance Aviation Services has lowered its FY26 earnings guidance significantly below analyst expectations, citing increased depreciation, higher maintenance costs, and a contract dispute. Despite these challenges, the company maintains profitability and a strong balance sheet.

St George Mining reports exceptional high-grade rare earth and niobium mineralisation at its Araxá Project in Brazil, alongside a strategic US partnership and a significant capital raise to fuel expansion.

TMK Energy Limited has successfully passed all resolutions at its recent General Meeting, including a significant share placement involving directors and a substantial consolidation of its capital structure.

Argent Minerals reports exceptional silver grades from deep drilling at Kempfield, alongside bonanza gold results at Trunkey Creek and new copper-gold targets at West Wyalong, supported by a $4.85 million capital raise.

TZ Limited reports steady sales growth and new Microsoft contracts in Q1 FY2026, reaffirming its $17–21 million revenue guidance amid improving market conditions.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Ragusa Minerals has agreed to acquire a controlling stake in Pegasus Tel Inc., gaining access to the Purple Pansy manganese-gold project in Arizona, a critical asset aligned with US strategic mineral priorities.

Imagion Biosystems has made significant strides toward filing an IND application for its MagSense® HER2 breast cancer imaging agent, supported by positive FDA feedback and a recent $3.5 million capital raise to fund upcoming clinical trials.

European Lithium Limited has launched a replacement options offer for holders of 205 million expiring options, with directors committing to fully participate and underwrite the offer pending shareholder approval at the upcoming AGM.

American West Metals has raised A$7 million at a premium to advance its West Desert Project, home to the largest and highest-grade indium resource in the US. The funding includes a strategic $2 million investment from Tribeca Investment Partners and aims to accelerate critical metals development amid supportive US policies.